ADPT stock

Adaptive Biotechnologies Corp (ADPT) financials · rev $142.4M

Adaptive Biotechnologies Corp (ADPT) rev $142.4M.

Cached annual income statement
LineFY2025FY2024
Revenue$277.0M$179.0M
Cost of Revenue$71.4M$72.1M
Gross Profit$205.6M$106.9M
Operating Income-$57.1M-$162.5M
Net Income-$59.5M-$159.5M
EPS (Diluted)$-0.39$-1.08
Cached annual balance sheet
LineFY2025FY2024
Total Assets$512.7M$539.4M
Current Assets$300.2M$283.8M
Cash & Equivalents$70.5M$47.9M
Inventory$9.8M$8.4M
PP&E$34.1M$48.6M
Total Liabilities$287.7M$336.9M
Current Liabilities$89.9M$98.1M
Short-term Debt$4.6M$865.0K
Long-term Debt$126.6M$132.4M
Total Debt$0$0
Shareholders' Equity$218.8M$202.7M
Retained Earnings-$1.36B-$1.30B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$46.0M-$95.2M
CapEx$3.0M$3.7M
Investing Cash Flow$38.0M$77.8M
Financing Cash Flow$30.4M$241.0K
Dividends Paid$0$0
Net Change in Cash$22.4M-$17.2M
Free Cash Flow-$48.9M-$98.9M

FAQ

What is ADPT P/E and revenue?

Adaptive Biotechnologies Corp (ADPT) rev $142.4M.

What is ADPT revenue?

Adaptive Biotechnologies Corp last cached revenue is $277.0M (FY2025).

Is ADPT profitable?

Adaptive Biotechnologies Corp last cached net income is -$59.5M.

What are ADPT total assets?

Adaptive Biotechnologies Corp last cached total assets are $512.7M.

What is ADPT free cash flow?

Adaptive Biotechnologies Corp last cached free cash flow is -$48.9M.

Not investment advice. Cached statements, not a live tape.